BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 17877955)

  • 1. [Carcinoma in situ of the breast].
    Laenkholm AV; Hoffmann J; Rank FE
    Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy of in situ carcinoma of the breast. EORTC Breast Group].
    Julien JP
    Praxis (Bern 1994); 1998 Apr; 87(15):520-3. PubMed ID: 9608248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic problems posed by sub-clinical breast cancers].
    EspiƩ M
    Contracept Fertil Sex; 1999 Apr; 27(4):298-305. PubMed ID: 10349773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapy strategies in carcinoma in situ of the breast].
    Mosny DS
    Praxis (Bern 1994); 1998 Apr; 87(15):516-9. PubMed ID: 9608247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast cancer: apropos of "in situ"].
    Hertens D; Sales F; Staquet E
    Rev Med Brux; 1995; 16(4):231-4. PubMed ID: 7481231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
    Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
    Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
    Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
    Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of carcinoma in situ of the breast].
    Raudrant D; Golfier F; Unger P
    Rev Fr Gynecol Obstet; 1990 Feb; 85(2):91-6. PubMed ID: 2157271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
    Cutuli B; de Lafontan B; Quetin P; Mery E
    Eur J Cancer; 2005 Feb; 41(3):380-5. PubMed ID: 15691636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy].
    Sautter-Bihl ML
    Strahlenther Onkol; 2001 Jan; 177(1):51-2. PubMed ID: 11200114
    [No Abstract]   [Full Text] [Related]  

  • 19. Lobular carcinoma in situ of the breast.
    Goldschmidt RA; Victor TA
    Semin Surg Oncol; 1996; 12(5):314-20. PubMed ID: 8873318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental finding of mammary carcinoma in lumpectomy specimens.
    Tang P; Hajdu SI; Conte CC; Filardi DA
    Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.